In addition, the combination of hIL-7/mIL-12-VV with anti-PD-L1 or CTLA4 antibodies showed a stronger antitumor effect in CT26 models, with complete regression in almost all mice without indications of cytokine storm despite the extent of tumor regression [107]. The gene discussed is CTLA4; the disease is neoplasm.